Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
Livzon Pharmaceutical Group Inc (Livzon Pharmaceutical), a subsidiary of Joincare Pharmaceutical Group Industry Co Ltd, is a pharmaceutical company. It carries out the pharmaceutical research and development, production, and sales. The company's products include shenqi fuzheng injection, human chorionic gonadotrophin for injection, ilaprazole enteric-coated tablets, tocilizumab injection, cetrorelix ccetate for injection, ilaprazole enteric-coated tablets, tocilizumab injection, valsartan vapsules, fluvoxamine maleate tablets, and others. Livzon Pharmaceutical's products serve customers in various fields such as digestive health, reproductive endocrinology, and immune diseases. The company operates across China. Livzon Pharmaceutical is headquartered in Zhuhai, Guangdong, China.
Headquarters
China
Address
Headquarter Building, No. 38, Chuangye North Road, Jinwan District, Zhuhai, Guangdong, 519090
Website
www.livzon.com.cn
Telephone
86 756 8135888
No of Employees
8,878
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
000513 (SHE)
Revenue (2024)
$1.7B
1.8%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
-1.8%
(2024 vs 2023)
Market Cap*
$3.1B
Net Profit Margin (2024)
XYZ
-3.6%
(2024 vs 2023)
* As of and is in US$
Livzon Pharmaceutical Group Inc premium industry data and analytics
Products and Services
| Products |
|---|
| Recombinant Human Chorionic Gonadotropin alfa for Injection (r-HCG) |
| Chorionic Gonadotrophin for Injection (HCG) |
| Menotrophin for Injection (HMG) |
| XYZ |
| XYZ |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Contracts/Agreements | In August, the company entered into an agreement to acquire a 3.5% stake in Xinbeijiang Pharma. |
| 2026 | Plans/Strategy | In January, the company announced its plans to acquire a 78% stake in Imexpharm. |
| 2025 | New Products/Services | In September, the company introduced an oral GnRH (gonadotropin-releasing hormone) antagonist. |
Competitor Comparison
| Key Parameters | Livzon Pharmaceutical Group Inc | Sinopharm Group Co Ltd | China National Accord Medicines Corporation Ltd | Beijing Tiantan Biological Products Co Ltd | Tianjin Chase Sun Pharmaceutical Co Ltd |
|---|---|---|---|---|---|
| Headquarters | China | China | China | China | China |
| City | Zhuhai | Shanghai | Shenzhen | Beijing | Tianjin |
| State/Province | Guangdong | Shanghai | Guangdong | Beijing | Tianjin |
| No. of Employees | 8,878 | 94,910 | 28,336 | 5,205 | 4,852 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Zhu Baoguo | Chairman | Executive Board | 2005 | 63 |
| Tang Yanggang | Director; Vice Chairman | Executive Board | 2026 | - |
| Liu Daping | President; Director | Executive Board | 2026 | - |
| Huang Yuxuan | Vice President | Senior Management | 2018 | 58 |
| Xu Xiao | Vice President | Senior Management | 2025 | 48 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer